SupplierRadar

Hoshino Seichaen

FDA import alert and refusal historyYame, JapanFEI 3004396878

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Hoshino Seichaen.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectHoshino Seichae added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Hoshino Seichaen is not on any FDA import alert in SupplierRadar's records; FDA refused 11 of its shipment lines between March 19, 2024 and August 2, 2024, most often for required information not conspicuous (INCONSPICU).

Data from FDA public records, last checked . Request a correction

Current status

Import alerts
Not listed
Last import refusal
Tea, green · NO ENGLISH
Last warning letter
None found
Last inspection
None on record

Every FDA record for Hoshino Seichaen

11 records, newest first. Each line links to the FDA page it came from.

2024

  1. Import refusal
    Refused, 2 lines in one entry: Tea, greenNO ENGLISHLACKS FIRMLACKS N/CUSUAL NAMEEntry AEK-5529507-3Show 2 lines
    Source
  2. Import refusal
    Refused, 9 lines in one entry: Tea, n.e.c.INCONSPICUNO ENGLISHLIST INGRELACKS FIRMEntry AEK-4648559-3Show 9 lines
    Source

Refusal charges, in plain English

  • INCONSPICU9 refused lines

    Required information not conspicuous

    Information required on the label appeared not to be placed prominently or conspicuously enough to be read and understood by an ordinary consumer.

  • NO ENGLISH9 refused lines

    Required label information not in English

    Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.

  • LACKS FIRM2 refused lines

    Manufacturer name and address missing

    The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.

  • LACKS N/C2 refused lines

    Net quantity statement missing

    The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

  • LIST INGRE1 refused line

    Ingredients not listed

    The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

  • USUAL NAME1 refused line

    Common or usual name missing

    The label appeared not to show the common or usual name of the food.

Questions about Hoshino Seichaen

Is Hoshino Seichaen on an FDA import alert?
No listing for Hoshino Seichaen appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Japan page.
Has FDA refused shipments from Hoshino Seichaen?
Yes. FDA refused 11 shipment lines from Hoshino Seichaen between March 19, 2024 and August 2, 2024. The most recent, on August 2, 2024, was tea, green, charged as NO ENGLISH (required label information not in english).
Why did FDA refuse Hoshino Seichaen's shipments?
The most frequent charges are INCONSPICU (required information not conspicuous, 9 lines) and NO ENGLISH (required label information not in english, 9 lines).
What is Hoshino Seichaen's FEI number?
Hoshino Seichaen's FDA Establishment Identifier (FEI) is 3004396878.

Buying from Hoshino Seichaen?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Hoshino Seichaen.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectHoshino Seichae added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.